SURMODICS INC — Director's Dealing 2020

Feb 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2020-02-12

Reporting Person: Sultana Nusrath (VP, Clinical Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-12	Common Stock	A	3276	$0.00	Acquired	3276	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-12	Employee Stock Option (right to buy)	$39.68	A	14264	Acquired	2027-02-12	Common Stock (14264)	Direct

Footnotes

F1: One third of the award vests on February 12, 2021 and the remainder of the award will vest on February 12, 2022.